Factors affecting the outcomes in stable chronic obstructive pulmonary disease patients at an Army Central Hospital

被引:0
作者
Nurwulandari, Nunik U. [1 ]
Zazuli, Zulfan [1 ]
Wihastuti, Retno [2 ]
Wikaningtyas, Pratiwi [1 ]
机构
[1] Bandung Inst Technol, Sch Pharm, Dept Pharmacol Clin Pharm, Bandung 40132, Indonesia
[2] Gatot Soebroto Army Cent Hosp, Dept Pulmonol, Jakarta, Indonesia
来源
PHARMACY PRACTICE-GRANADA | 2024年 / 22卷 / 01期
关键词
COPD; clinical outcomes; factors; therapeutic outcomes; LUNG-FUNCTION; RISK-FACTORS; ALCOHOL-CONSUMPTION; COPD; BURDEN; COMORBIDITIES; TUBERCULOSIS; PREVALENCE; MANAGEMENT; SYMPTOMS;
D O I
10.18549/PharmPract.2024.1.2903
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Of the four Asian countries, Indonesian COPD patients have the worst clinical features, which puts them at a high risk for treatment failure. There are a number of variables and patient traits that influence clinical results as a predictor of therapy outcomes. Objective: to identify the contributing components and how much they influence COPD patients' therapy results. Methods: This cross-sectional descriptive-observational study at a tertiary army hospital involved 74 patients. A questionnaire and medical records were utilized to obtain sociodemographic characteristics and clinical data. Correlation and logistic regression analysis were conducted to identify significant factors. Results: The results showed that tumor/cancer comorbidities affected the worsening of CAT values (OR=10.89, 95%CI=1.01-117.23, p=0.049), use of ICS/LABA drugs affected the improvement of mMRC values (OR= 0.26, 95%CI=0.08-0.84, p=0.024), history of TBC disease affected the increase in exacerbation severity (OR=7.25, 95%CI=1.05-50.23, p=0.045), age from smoking >20 years affected the reduction in exacerbation severity (OR=0.03, 95%CI=0.002-0.61, p=0.022). History of alcohol use (OR=7.26 and 167.56, p=0.014 and 0.004) and comorbid pneumonia (OR=28.14 and 44.25, p=0.035 and 0.014) contributed to an increase in the frequency of exacerbations and hospitalization per year. Medium economic status affects the decrease in hospitalizations per year (OR=0.06, 95%CI=0.00-0.91, p=0.043) while the diagnosis of severe COPD and history of alcohol affected the decrease in COPD severity (ABCD) (OR=0.12 and 0.24, p=0.039 and 0.009). Conclusion: comorbidities, disease history, history of alcohol use, COPD status and the use of COPD medications contributed to variations therapeutic outcomes COPD patients. Therefore, it must be taken into account when making clinical decisions.
引用
收藏
页数:16
相关论文
共 61 条
  • [31] Langefeld K, 2022, Global Strategy for Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, V2022nd, P1
  • [32] Effects of Air Pollutants on Airway Diseases
    Lee, Yun-Gi
    Lee, Pureun-Haneul
    Choi, Seon-Muk
    An, Min-Hyeok
    Jang, An-Soo
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (18)
  • [33] Interaction of Depressive and Anxiety Symptoms on the Mortality of Patients with COPD: A Preliminary Study
    Lou, Peian
    Zhu, Yanan
    Chen, Peipei
    Zhang, Pan
    Yu, Jiaxi
    Wang, Yong
    Chen, Na
    Zhang, Lei
    Wu, Hongmin
    Zhao, Jing
    [J]. COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2014, 11 (04) : 444 - 450
  • [34] Platelet function in diabetic and nondiabetic patients with chronic obstructive pulmonary disease: a case control study
    Makhlouf, Hoda Ahmed
    Sadek, Samiaa Hamdy
    Nafady, Asmaa Abdel Hakim
    [J]. CLINICAL RESPIRATORY JOURNAL, 2018, 12 (01) : 48 - 56
  • [35] Global burden of COPD: risk factors, prevalence, and future trends
    Mannino, David M.
    Buist, A. Sonia
    [J]. LANCET, 2007, 370 (9589) : 765 - 773
  • [36] Economic Burden of COPD in the Presence of Comorbidities
    Mannino, David M.
    Higuchi, Keiko
    Yu, Tzy-Chyi
    Zhou, Huanxue
    Li, Yangyang
    Tian, Haijun
    Suh, Kangho
    [J]. CHEST, 2015, 148 (01) : 138 - 150
  • [37] Association between Occupational Exposure and Lung Function, Respiratory Symptoms, and High-Resolution Computed Tomography Imaging in COPDGene
    Marchetti, Nathaniel
    Garshick, Eric
    Kinney, Gregory L.
    McKenzie, Alex
    Stinson, Douglas
    Lutz, Sharon M.
    Lynch, David A.
    Crinerl, Gerard J.
    Silverman, Edwin K.
    Crapo, James D.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 190 (07) : 756 - 762
  • [38] VALUE OF THEOPHYLLINE TREATMENT IN PATIENTS HANDICAPPED BY CHRONIC OBSTRUCTIVE LUNG-DISEASE
    MCKAY, SE
    HOWIE, CA
    THOMSON, AH
    WHITING, B
    ADDIS, GJ
    [J]. THORAX, 1993, 48 (03) : 227 - 232
  • [39] Accelerated ageing of the lung in COPD: new concepts
    Mercado, Nicolas
    Ito, Kazuhiro
    Barnes, Peter J.
    [J]. THORAX, 2015, 70 (05) : 482 - 489
  • [40] Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort
    Miller, Joy
    Edwards, Lisa D.
    Agusti, Alvar
    Bakke, Per
    Calverley, Peter M. A.
    Celli, Bartolome
    Coxson, Harvey O.
    Crim, Courtney
    Lomas, David A.
    Miller, Bruce E.
    Rennard, Steve
    Silverman, Edwin K.
    Tal-Singer, Ruth
    Vestbo, Jorgen
    Wouters, Emiel
    Yates, Julie C.
    MacNee, William
    [J]. RESPIRATORY MEDICINE, 2013, 107 (09) : 1376 - 1384